LOSS PER SHARE (EPS) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
NUMERATOR [Abstract]
Basic and diluted - loss from continuing operations	$ (3,326)	$ (1,627)	$ (9,996)	$ (5,700)
DENOMINATOR [Abstract]
Basic EPS - weighted average number of common shares outstanding (in shares)	33,057,010	24,092,172	31,947,087	20,538,309
Effect of dilutive securities outstanding (in shares)	0	0	0	0
Diluted EPS - weighted average number of shares outstanding (in shares)	33,057,010	24,092,172	31,947,087	20,538,309
Stock Options [Member]
Antidilutive Securities [Abstract]
Number of shares of common stock which could be purchased with weighted average outstanding securities not included in diluted EPS because effect would be antidilutive (in shares)	969,566	790,950	1,034,218	843,910
Warrants [Member]
Antidilutive Securities [Abstract]
Number of shares of common stock which could be purchased with weighted average outstanding securities not included in diluted EPS because effect would be antidilutive (in shares)	7,712,225	14,421,219	8,744,733	17,840,322
Convertible Preferred Stock [Member]
Antidilutive Securities [Abstract]
Number of shares of common stock which could be purchased with weighted average outstanding securities not included in diluted EPS because effect would be antidilutive (in shares)	213,523	597,865	228,540	597,865
Restricted Stock Units [Member]
Antidilutive Securities [Abstract]
Number of shares of common stock which could be purchased with weighted average outstanding securities not included in diluted EPS because effect would be antidilutive (in shares)	1,138,442	178,478	1,263,275	428,132
Nonvested Shares of Common Stock [Member]
Antidilutive Securities [Abstract]
Number of shares of common stock which could be purchased with weighted average outstanding securities not included in diluted EPS because effect would be antidilutive (in shares)	475,567	1,079,079	848,699	1,198,913